News
People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given ...
A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...
COPENHAGEN (Reuters) -Drugmaker Novo Nordisk said on Monday it would halt its Wegovy weight-loss drug agreement with U.S.
Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.
CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...
Prescriptions for Mounjaro jabs, to help people lose weight, will be available at GP surgeries in England from today - but ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Omnicom's $13.5 billion acquisition of rival Interpublic can move forward on the condition the new company does not enter ...
Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...
GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...
The shipments have propelled Ireland, a country of only 5.4 million people, to the second-largest goods-trade imbalance with ...
An experimental weight-loss medication was shown to help people lose nearly 25% of their body weight in early-stage 1a/2b trials. The drug, amycretin — developed by Novo Nordisk — works by replicating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results